Family

Loading Family data...

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
SANTEN PHARMACEUTICAL CO LTD	9-19 SHIMOSHINJO 3-CHOME HIGASHIYODOGAWA-KU OSAKA-SHI OSAKA 533-8651

International Classification(s)

• C07D:HETEROCYCLIC COMPOUNDS

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Kato, Masatomo	Ikoma, JP	27	100
# of filed Patents : 27 Total Citations : 100
Kobayashi, Sachiko	Ikoma, JP	62	489
# of filed Patents : 62 Total Citations : 489
Matsuda, Mamoru	Ikoma, JP	17	101
# of filed Patents : 17 Total Citations : 101
Mori, Toshiyuki	Ikoma, JP	55	417
# of filed Patents : 55 Total Citations : 417
Nagatsuka, Masato	Ikoma, JP	14	81
# of filed Patents : 14 Total Citations : 81
Takai, Miwa	Ikoma, JP	17	108
# of filed Patents : 17 Total Citations : 108

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
11.5 Year Payment	$7400.00	$3700.00	$1850.00	Apr 29, 2025

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

DATE PUBLISHED	PUBLICATION/PATENT NO.	PUBLICATION TYPE
October 29, 2013	US,8569493,B2   US8569493B2	GRANTED PATENT AS SECOND PUBLICATION
May 24, 2012	US,20120129866,A1   US20120129866A1	FIRST PUBLISHED PATENT APPLICATION

Full Text

US Patent No: 8569493

Method for treating a homeostasis-related disease or glaucoma by administering a 1,2,3,4-tetrahyroquinoxaline compound

---

Abstract

---

A method for preventing or treating a metabolic disorder, an inflammatory disease, an autoimmune disease, an allergic disease, a central nervous system disease, a cardiovascular disease, a homeostasis-related disease or glaucoma, involving administering a compound or a salt thereof, the compound having the following formula (1):

---

 

---

Description

---

Claims

---

Claims data not available

---

Legal Events

 

• STCH2017
• LAPS2017
• FP2017
• REMI2017
• I2013
• P2012
• F2012
• AS2009
• PD2007

Date	Code	Event	Description
Dec 07, 2017	STCH	INFORMATION ON STATUS: PATENT DISCONTINUATION	free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362
Nov 27, 2017	LAPS	LAPSE FOR FAILURE TO PAY MAINTENANCE FEES	free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.)
Oct 29, 2017	FP	LAPSED DUE TO FAILURE TO PAY MAINTENANCE FEE	Effective Date: Oct 29, 2017
Jun 09, 2017	REMI	MAINTENANCE FEE REMINDER MAILED
Oct 29, 2013	I	Issuance
May 24, 2012	P	Published
Feb 02, 2012	F	Filing
Aug 28, 2009	AS	ASSIGNMENT	free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MATSUDA, MAMORU;MORI, TOSHIYUKI;NAGATSUKA, MASATO;AND OTHERS;REEL/FRAME:027642/0180 Owner name: SANTEN PHARMACEUTICAL CO., LTD., JAPAN Effective Date: Aug 28, 2009
May 29, 2007	PD	Priority Date